Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Scilex Holding Co. (SCLX)

Scilex Holding Co. (SCLX)
4.33 +0.27 (+6.65%) 15:24 ET [NASDAQ]
4.27 x 1 4.36 x 3
Realtime by (Cboe BZX)
4.27 x 1 4.36 x 3
Realtime 4.10 +0.04 (+0.99%) 09:27 ET
Quote Overview for Thu, Apr 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
4.00
Day High
4.59
Open 4.10
Previous Close 4.06 4.06
Volume 127,905 127,905
Avg Vol 109,975 109,975
Stochastic %K 7.29% 7.29%
Weighted Alpha -91.90 -91.90
5-Day Change -1.84 (-30.15%) -1.84 (-30.15%)
52-Week Range 3.60 - 80.50 3.60 - 80.50
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 28,252
  • Shares Outstanding, K 6,959
  • Annual Sales, $ 56,590 K
  • Annual Income, $ -72,810 K
  • EBIT $ -79 M
  • EBITDA $ -75 M
  • 60-Month Beta 1.04
  • Price/Sales 0.49
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 140.64%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 701.38% on 01/03/25
  • IV Low 0.00% on 04/21/25
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 42
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 4,181
  • Open Int (30-Day) 4,882

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -2.97
  • Number of Estimates 2
  • High Estimate -1.75
  • Low Estimate -4.20
  • Prior Year -9.09
  • Growth Rate Est. (year over year) +67.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.60 +18.75%
on 04/22/25
Period Open: 9.66
11.59 -63.10%
on 04/02/25
-5.38 (-55.75%)
since 03/24/25
3-Month
3.60 +18.75%
on 04/22/25
Period Open: 15.41
16.80 -74.55%
on 01/27/25
-11.14 (-72.27%)
since 01/24/25
52-Week
3.60 +18.75%
on 04/22/25
Period Open: 29.75
80.50 -94.69%
on 06/17/24
-25.48 (-85.63%)
since 04/24/24

Most Recent Stories

More News
Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from April 11,...

SCLX : 4.33 (+6.65%)
Scilex Holding Company Announces FDA Has Approved Our Request for the Orphan Drug Designation for Colchicine for the Treatment of Pericarditis

SCLX : 4.33 (+6.65%)
Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for ELYXYB®’s Acute Treatment of Migraine With or Without...

SCLX : 4.33 (+6.65%)
Scilex Holding Company Announces 1-for-35 Reverse Stock Split

SCLX : 4.33 (+6.65%)
Scilex Holding Company Has Appealed Lower Court Decision to the U.S. Court of Appeals for the Federal Circuit in Washington, DC and Will Continue to Vigorously Pursue its Infringement Action Against Aveva

SCLX : 4.33 (+6.65%)
Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from January 28,...

SCLX : 4.33 (+6.65%)
Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025

SCLX : 4.33 (+6.65%)
Scilex Holding Company Announces that the U.S. FDA Has Acknowledged the Submission of Our Supplemental New Drug Application for ELYXYB® in Acute Pain Indication

SCLX : 4.33 (+6.65%)
Scilex Holding Company Announces that It Regains Nasdaq Compliance Under Listing Rule 5250(c)(1)

SCLX : 4.33 (+6.65%)
Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025

SCLX : 4.33 (+6.65%)

Business Summary

Scilex Holding Company is a commercial biopharmaceutical company focused on developing and commercializing non-opioid therapies for patients with acute and chronic pain. Scilex Holding Company, formerly known as Vickers Vantage Corp. I, is based in PALO ALTO, Calif.

See More

Key Turning Points

3rd Resistance Point 5.87
2nd Resistance Point 5.41
1st Resistance Point 4.73
Last Price 4.33
1st Support Level 3.59
2nd Support Level 3.13
3rd Support Level 2.45

See More

52-Week High 80.50
Fibonacci 61.8% 51.12
Fibonacci 50% 42.05
Fibonacci 38.2% 32.98
Last Price 4.33
52-Week Low 3.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective